Osborne Clarke has advised Turbine on the deal. Turbine, a company simulating cellular decision making to unlock novel oncology therapies, raised EUR 5.7 million (USD 6.85m)…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
